Cognitive Level Enhancement through Vision Exams and Refraction (CLEVER): study protocol for a randomised controlled trial.
Srinivas Marmamula, Suvarna Alladi, Keerthana Umapathy...
https://pubmed.ncbi.nlm.nih.gov/40156032Actively Recruiting
Led by Queen's University, Belfast · Updated on 2026-03-06
820
Participants Needed
1
Research Sites
56 weeks
Total Duration
Q
Queen's University, Belfast
Lead Sponsor
L
L.V. Prasad Eye Institute
Collaborating Sponsor
Researchers are evaluating whether providing free near and distance glasses to older adults in Hyderabad, India, aged 60 years and above, with under- or uncorrected vision problems can improve their quality of life and slow cognitive decline. This mixed-method study combines a randomized controlled trial (RCT) with a qualitative component to understand the cultural context and lived experiences of participants with reduced vision. The study also aims to assess the impact of vision correction on reducing falls, depression, social isolation, and physical activity over a period of 36 months. Participants are randomly assigned to one of two groups. Those in the intervention group receive free spectacles for near and/or distance vision at the start of the study, with options to choose from 20 frames. They will have annual eye exams and refractions to adjust or replace glasses as needed. The control group receives prescriptions and free glasses only at the end of the study. Cataract surgery is provided at no cost for those recommended during follow-ups. Annual assessments continue for three years, including home visits for participants unable to attend clinic visits. During the study, participants undergo evaluations of cognitive function, quality of life, visual functioning, physical activity, depression, social interactions, cost of care, and number of falls. Researchers use various questionnaires and cognitive tests at baseline and every 12 months until 36 months. The study also tracks compliance with spectacle use and cataract surgery outcomes. Safety and follow-up data, including reasons for any loss to follow-up, are carefully recorded to support comprehensive analysis of the intervention's effects.
CONDITIONS
Cognitive Level Enhancement Through Vision Exams and Refraction
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At enrollment and ongoing as needed
Participants who are randomized to the intervention group receive free near and/or distance vision glasses based on refraction results. Glasses are provided at enrollment. Participants are asked to report any issues or if glasses are lost or broken, with replacements provided as needed.
1 baseline visit with additional visits as needed for glasses replacement
Duration - Annual follow-ups for 3 years
Participants undergo annual eye exams and refraction, with changes in glasses prescribed as needed. The study also includes annual follow-up visits for cognitive and other assessments, with home visits offered for participants unable to attend in person.
Annual visits for up to 3 years with possible home visits
Duration - Up to 3 years during follow-up
Participants advised for cataract surgery are followed up to support getting surgery done at no cost. Spectacle compliance contacts also occur during follow-up.
Additional follow-up contacts as needed for cataract surgery and spectacle compliance
Total: 1 location
1
L V Prasad Eye Institute
Hyderabad, Telangana, India, 500086
Actively Recruiting
N
Nathan G Congdon, MD, MPH
R
Rohit C Khanna, MPH
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Srinivas Marmamula, Suvarna Alladi, Keerthana Umapathy...
https://pubmed.ncbi.nlm.nih.gov/40156032